Manufacturers planning to put into practice these methods will have to provide sturdy validation facts to show their equivalence to pharmacopoeial techniques. As these new technologies arise, the WHO emphasizes the significance of an intensive danger assessment and validation system. As the planet market chief while in the pharmaceutical